163 related articles for article (PubMed ID: 9049578)
1. Pharmacological properties of nebivolol in man.
Van Bortel LM; de Hoon JN; Kool MJ; Wijnen JA; Vertommen CI; Van Nueten LG
Eur J Clin Pharmacol; 1997; 51(5):379-84. PubMed ID: 9049578
[TBL] [Abstract][Full Text] [Related]
2. Exercise tolerance with nebivolol and atenolol.
Van Bortel LM; van Baak MA
Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.
Van Nueten L; De Crée J
Cardiovasc Drugs Ther; 1998 Sep; 12(4):339-44. PubMed ID: 9825177
[TBL] [Abstract][Full Text] [Related]
5. Determination of the anti-ischemic activity of nebivolol in comparison with atenolol.
Ruf G; Trenk D; Jähnchen E; Roskamm H
Int J Cardiol; 1994 Mar; 43(3):279-85. PubMed ID: 7910155
[TBL] [Abstract][Full Text] [Related]
6. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
[TBL] [Abstract][Full Text] [Related]
7. A comparison of atenolol and nebivolol in isolated systolic hypertension.
Dhakam Z; Yasmin ; McEniery CM; Burton T; Brown MJ; Wilkinson IB
J Hypertens; 2008 Feb; 26(2):351-6. PubMed ID: 18192850
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
De Crée J; Cobo C; Geukens H; Verhaegen H
Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
[TBL] [Abstract][Full Text] [Related]
11. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat.
Schneider J; Fruh C; Wilffert B; Peters T
Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437
[TBL] [Abstract][Full Text] [Related]
12. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
Kubli S; Feihl F; Waeber B
Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol increases arterial distensibility in vivo.
McEniery CM; Schmitt M; Qasem A; Webb DJ; Avolio AP; Wilkinson IB; Cockcroft JR
Hypertension; 2004 Sep; 44(3):305-10. PubMed ID: 15262912
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
Simon G; Johnson ML
Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol: endothelium-mediated vasodilating effect.
Ritter JM
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide mediated venodilator effects of nebivolol.
Bowman AJ; Chen CP; Ford GA
Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
[TBL] [Abstract][Full Text] [Related]
18. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
[TBL] [Abstract][Full Text] [Related]
19. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
